SEC
KYTH

Seven Eight Capital’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Seven Eight Capital’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,200
Closed -$90K – 780
2015
Q3 		$90K Buy
+1,200
New +$89.6K 0.08% 290

Seven Eight Capital's KYTH Position: Q4 2015 in Review

Seven Eight Capital sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 1,200 shares — an estimated $90K sold.

Seven Eight Capital first reported a position in KYTH in Q3 2015 and held it in 1 quarter. The position peaked at $90K in Q3 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

  • Seven Eight Capital reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
  • Seven Eight Capital sold 1,200 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $90K.
  • Seven Eight Capital first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q3 2015 and held it in 1 quarter.
  • Seven Eight Capital's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $90K in Q3 2015.
  • 0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Seven Eight Capital's 13F filing for Q4 2015, filed 16 Feb 2016.